13 Matching Annotations
  1. Last 7 days
    1. Urgent treatment for neoplasm consists of (1) cautious use of intravenous diuretics and (2) mediastinal irradiation, starting within 24 hours, with a treatment plan designed to give a high daily dose of radiation but a short total course of therapy to rapidly shrink the local tumor. Intensive radiation therapy combined with chemotherapy will palliate the process in up to 90% of patients. In patients with a subacute presentation, radiation therapy alone usually suffices. Chemotherapy is added if lymphoma or small-cell carcinoma is diagnosed

      endovascular stenting emerging as first-line therapy for rapid symptom relief, while definitive treatment targets the underlying cause

      Glucocorticoids (dexamethasone 4 mg every 6 hours) are commonly prescribed but lack robust supporting data; they may be more beneficial in lymphoma or thymoma and as prophylaxis against radiation-induced edema. [2-4] Importantly, SVC syndrome is no longer considered a medical emergency except in rare cases with life-threatening cerebral edema, laryngeal edema, or altered mental status. When thrombosis is present, catheter-directed thrombolysis or aspiration thrombectomy should be performed within 2-5 days of symptom onset before thrombus organization occurs. [3] The role of long-term anticoagulation after stenting remains unclear, though it is standard when significant thrombosis is present The American College of Chest Physicians recommends obtaining histologic diagnosis before treatment in suspected lung cancer cases, as stenting does not interfere with tissue diagnosis. [2] For small cell lung cancer (SCLC), chemotherapy alone is recommended as first-line treatment given rapid response rates. [2] For non-small cell lung cancer (NSCLC), radiation therapy and/or stent insertion are recommended, with response rates of 59% for chemotherapy and 63% for radiation therapy. [2] Patients with chemotherapy- or radiation-refractory disease should receive vascular stents For device-related thrombosis (catheters, pacemakers), catheter removal should be considered in conjunction with anticoagulation. [4] Endovascular therapy is first-line for device-related obstruction, while surgical bypass may be preferred for mediastinal fibrosis. [7] Both approaches show good mid-term patency, though secondary interventions are common (approximately 27-28%

    Tags

    Annotators

    URL

  2. Aug 2022
  3. Apr 2022
  4. Oct 2021
  5. Aug 2021
    1. Tenbusch, M., Schumacher, S., Vogel, E., Priller, A., Held, J., Steininger, P., Beileke, S., Irrgang, P., Brockhoff, R., Salmanton-García, J., Tinnefeld, K., Mijocevic, H., Schober, K., Bogdan, C., Yazici, S., Knolle, P., Cornely, O. A., Überla, K., Protzer, U., … Wytopil, M. (2021). Heterologous prime–boost vaccination with ChAdOx1 nCoV-19 and BNT162b2. The Lancet Infectious Diseases, 0(0). https://doi.org/10.1016/S1473-3099(21)00420-5

  6. Apr 2021
    1. Jeremy Faust MD MS (ER physician) on Twitter: “Let’s talk about the background risk of CVST (cerebral venous sinus thrombosis) versus in those who got J&J vaccine. We are going to focus in on women ages 20-50. We are going to compare the same time period and the same disease (CVST). DEEP DIVE🧵 KEY NUMBERS!” / Twitter. (n.d.). Retrieved April 15, 2021, from https://twitter.com/jeremyfaust/status/1382536833863651330

    1. ReconfigBehSci. ‘@sarahflecke “Reports Emerging of Rare Types of Multiple Thrombosis, Bleeding, and Thrombocytopenia .. Similar to Disseminated Intravasc. Coagulation ... in Otherwise Healthy Individuals Shortly after Receiving ..AstraZeneca ..Vaccine. These Outcomes Are Not Included in the Present Analysis.”’ Tweet. @SciBeh (blog), 2 April 2021. https://twitter.com/SciBeh/status/1377984798422077446.

  7. Mar 2021
  8. Jul 2020